Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence

British Journal of Surgery

Volumn 96, Issue 11, 2009, Pages 1289-1294

  Murawa, D ^a,b   Hirche, C ^a   Dresel, S ^a   Hunerbein M ^a  

^a Section of Pathology   (Germany)

^b Wielkopolska Cancer Center   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; NANOCIS; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG MEGADOSE; FALSE NEGATIVE RESULT; FEMALE; FLUORESCENCE; HUMAN; INTRADUCTAL CARCINOMA; LUNG CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL; PRIORITY JOURNAL; SCINTIGRAPHY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COLORING AGENTS; FEASIBILITY STUDIES; FEMALE; HUMANS; INDOCYANINE GREEN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY;

EID: 70350508287     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6721     Document Type: Article

References (31)

1. Bonnema J, van de Velde CJ. Sentinel lymph node biopsy in breast cancer. Ann Oncol 2002; 13: 1531-1537. (Pubitemid 35331450)
2. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002; 20: 3628-3636. (Pubitemid 34983222)
3. Purushotham AD, Macmillan RD, Wishart GC. Advances in axillary surgery for breast cancer - time for a tailored approach. Eur J Surg Oncol 2005; 31: 929-931. (Pubitemid 41671103)
4. Langer I, Guller U, Berclaz G, Koechli OR, Schaer G, Fehr MK et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 2007; 245: 452-461. (Pubitemid 46673142)
5. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000; 88: 608-614. (Pubitemid 30056936)
6. Tuttle TM, Zogakis TG, Dunst CM, Zera RT, Singletary SE. A review of technical aspects of sentinel lymph node identification for breast cancer. J Am Coll Surg 2002; 195: 261-268. (Pubitemid 34832686)
7. Sandrucci S, Casalegno PS, Percivale P, Mistrangelo M, Bombardieri E, Bertoglio S. Sentinel lymph node mapping and biopsy for breast cancer: a review of the literature relative to 4791 procedures. Tumori 1999; 85: 425-434. (Pubitemid 30074587)
8. Hung WK, Chan CM, Ying M, Chong SF, Mak KL, Yip AW. Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer. Br J Surg 2005; 92: 1494-1497. (Pubitemid 41785287)
9. Stratmann SL, McCarty TM, Kuhn JA. Radiation safety with breast sentinel node biopsy. Am J Surg 1999; 178: 454-457. (Pubitemid 30058290)
10. Sardi A, Spiegler E, Colandrea J, Frishberg D, Sing H, Regan P et al. The benefit of using two techniques for sentinel lymph node mapping in breast cancer. Am Surg 2002; 68: 24-28. (Pubitemid 44943237)
11. Ueno H, Hihara J, Shimizu K, Osaki A, Yamashita Y, Yoshida K et al. Experimental study on fluorescent microspheres as a tracer for sentinel node detection. Anticancer Res 2005; 25: 821-825. (Pubitemid 40546849)
12. Zavagno G, De Salvo GL, Casara D, Del Bianco P, Rubello D, Meggiolaro F et al. Sentinel node biopsy for breast cancer: is it already a standard of care? A survey of current practice in an Italian region. BMC Cancer 2004; 4: 2. (Pubitemid 38851371)
13. Meyer JS. Sentinel lymph node biopsy: strategies for pathologic examination of the specimen. J Surg Oncol 1998; 69: 212-218. (Pubitemid 29024564)
14. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24 740 breast cancer cases. Cancer 1989; 63: 181-187. (Pubitemid 19032001)
15. Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JN. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 2006; 93: 539-546.
16. Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000; 18: 2553-2559. (Pubitemid 30432521)
17. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-1867. (Pubitemid 27270119)
18. de Kanter AY, Menke-Pluymers MM, Wouters MW, Burgmans I, van Geel AN, Eggermont AM. 5-Year follow-up of sentinel node negative breast cancer patients. Eur J Surg Oncol 2006; 32: 282-286.
19. Langer I, Marti WR, Guller U, Moch H, Harder F, Oertli D et al. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 2005; 241: 152-158. (Pubitemid 40041004)
20. Branagan G, Hughes D, Jeffrey M, Crane-Robinson C, Perry PM. Detection of micrometastases in lymph nodes from patients with breast cancer. Br J Surg 2002; 89: 86-89. (Pubitemid 34031314)
21. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-339.
22. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-398.
23. Kohso H, Tatsumi Y, Fujino H, Tokita K, Kodama T, Kashima K et al. An investigation of an infrared ray electronic endoscope with a laser diode light source. Endoscopy 1990; 22: 217-220. (Pubitemid 20334031)
24. Koyama T, Tsubota A, Nariai K, Mitsunaga M, Yanaga K, Takahashi H. Novel biomedical imaging approach for detection of sentinel nodes in an experimental model of gastric cancer. Br J Surg 2007; 94: 996-1001. (Pubitemid 47236545)
25. Nimura H, Narimiya N, Mitsumori N, Yamazaki Y, Yanaga K, Urashima M. Infrared ray electronic endoscopy combined with indocyanine green injection for detection of sentinel nodes in gastric cancer. Br J Surg 2004; 91: 575-579. (Pubitemid 38624665)
26. Kusano M, Tajima Y, Yamazaki K, Kato M, Watanabe M, Miwa M. Sentinel node mapping guided by indocyanine green fluorescence imaging: a new method for sentinel node navigation surgery in gastroinetstinal cancer. Dig Surg 2008; 25: 103-108. (Pubitemid 351748763)
27. Motomura K, Inaji H, Komoike Y, Kasugai T, Noguchi S, Koyama H. Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn J Clin Oncol 1999; 29: 604-607.
28. Ogasawara Y, Ikeda H, Takahashi M, Kawasaki K, Doihara H. Evaluation of breast lymphatic pathways with indocyanine green fluorescence imaging in patients with breast cancer. World J Surg 2008; 32: 1924-1929.
29. Flett MM, Going JJ, Stanton PD, Cooke TG. Sentinel node localization in patients with breast cancer. Br J Surg 1998; 85: 991-993. (Pubitemid 28341577)
30. Goyal A, Newcombe RG, Mansel RE; Axillary Lymphatic Mapping Against Nodal Axillary Clearance (ALMANAC) Trialists Group. Clinical relevance of multiple sentinel nodes in patients with breast cancer. Br J Surg 2005; 92: 438-442. (Pubitemid 40523906)
31. Tanaka E, Choi HS, Fujii H, Bawendi MG, Frangioni JV. Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol 2006; 13: 1671-1681. (Pubitemid 44951476)